We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mouth Swab Molecular Test for Tuberculosis Validated

By LabMedica International staff writers
Posted on 22 Jan 2020
Clinical investigators are testing an approach being developed to diagnose tuberculosis using mouth swabs, which could become an alternate approach to sample collection methods currently used to do tuberculosis (TB) testing.

Partly because of the convenience of the collection method, the technique is helping increase access to testing and finding people with TB that have been undetected by traditional testing methods. For individuals with latent TB infection, the host maintains a dynamic relationship with Mycobacterium tuberculosis through the regulation of available nutrients as well as the innate and acquired immune systems.

Image: PrimeStore Molecular Transport Medium (MTM) is the first molecular transport device designed to inactivate pathogens and stabilize both RNA and DNA for downstream molecular testing and characterization (Photo courtesy of Longhorn Vaccines and Diagnostics).
Image: PrimeStore Molecular Transport Medium (MTM) is the first molecular transport device designed to inactivate pathogens and stabilize both RNA and DNA for downstream molecular testing and characterization (Photo courtesy of Longhorn Vaccines and Diagnostics).

Scientists at the University of Pretoria (Pretoria, South Africa) and their colleagues collected and tested samples from people during house visits in an urban setting in South Africa with a high prevalence of TB and human immunodeficiency viruses (HIV). The team used flocked swabs to collect oral salivary specimens from 73 adults. Each person had a cough and one or more risk factors for TB, including previous TB, or was asymptomatic but residing with someone diagnosed with TB.

The investigators combined the swab samples that they had collected with PrimeStore Molecular Transport Medium (MTM, Longhorn Vaccines and Diagnostics, San Antonio, TX, USA) to enable microbial inactivation, DNA stabilization, and transportation of the specimens at ambient temperature to a nearby laboratory. The group detected M. tuberculosis DNA in 24, or 32.9%, of the 73 samples using Longhorn's polymerase chain reaction (PCR) diagnostic assay running on a Roche LightCycler platform (Roche Diagnostics, Basel, Switzerland).

P. Bernard Fourie, PhD, a professor of medical microbiology and TB specialist, said, “The approach holds promise as an easy to perform, safe, and patient-friendly procedure for triaging people who are presumed to have TB at the household level, and it provides a basis for targeted patient follow-up.”

Related Links:
University of Pretoria
Longhorn Vaccines and Diagnostics
Roche Diagnostics



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets

Latest Microbiology News

Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
22 Jan 2020  |   Microbiology

Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
22 Jan 2020  |   Microbiology

Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
22 Jan 2020  |   Microbiology



PURITAN MEDICAL